A network meta-analysis for the comparison of efficacy and safety of interleukin (IL)-23 targeted drugs in the treatment of moderate to severe psoriasis.

Shi, Jianzhen; Xu, Jianru; Chen, Yanmei

Shi, Jianzhen; Xu, Jianru; Chen, Yanmei.

Afiliación

Shi J; Nantong University Xinglin College, NanTong, Jiangsu, China.
Xu J; Department of Emergency, Nantong Third People's Hospital, NanTong, Jiangsu, China.
Chen Y; School of Environmental and Chemical Engineering, Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, China.

Dermatol Ther ; 33(4): e13802, 2020 07.

Article en En | MEDLINE | ID: mdl-32521069

Asunto(s)

Preparaciones Farmacéuticas; Psoriasis; Humanos; Interleucina-23; Metaanálisis en Red; Psoriasis/diagnóstico; Psoriasis/tratamiento farmacológico; Ustekinumab/efectos adversos

Palabras clave

guselkumab; network meta-analysis; physician global assessment; psoriasis area and severity index; risankizumab; tildrakizumab; ustekinumab

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Preparaciones Farmacéuticas Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google